Dergiler / The anatolian journal of family medicine (Online) / 2020 / Cilt: 3 - Sayı: 2

Evaluation of Metabolic Syndrome Prevalence and Parameters in Patients with Fibromyalgia

Sayfa
167–172
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

For a definitive conclusion on the MetS and fibromyalgia, further large-scale studiesare needed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: We aimed to evaluate the metabolic syndrome (MetS) parameters in patients with fibromyalgiasyndrome.Methods: Age, weight, height, body mass index, waist and hip circumferences, and blood pressure were recorded.
📊
Temel Bulgular & Veri:Laboratory parameters included fasting blood glucose and insulin, high-density lipoprotein, and triglyceride, HOMA-IR.Results: Thirty-five female patients aged 20-64 years with fibromyalgia and 29 age-matched healthy controlswere included in this case-control study.
💡
Sonuç & Katkı:For a definitive conclusion on the MetS and fibromyalgia, further large-scale studiesare needed.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: We aimed to evaluate the metabolic syndrome (MetS) parameters in patients with fibromyalgiasyndrome.Methods: Age, weight, height, body mass index, waist and hip circumferences, and blood pressure were recorded. Laboratory parameters included fasting blood glucose and insulin, high-density lipoprotein, and triglyceride, HOMA-IR.Results: Thirty-five female patients aged 20-64 years with fibromyalgia and 29 age-matched healthy controlswere included in this case-control study. Although MetS was more prevalent in fibromyalgia patients than thecontrol group, the difference did not reach a statistically significant level [7 (20.0%) vs. 5 (17.2%), p=0.770]. Theprevalence of high waist circumference was significantly higher in the fibromyalgia group than the controlgroup [23 (65.7%) vs. 6 (20.7%), p<0.001]. High blood pressure was also more prevalent in fibromyalgia group[10 (28.6%) vs. 1 (3.4%), p=0.009]. Insulin resistance and dyslipidemia prevalence did not show a significantdifference between groups (p=0.830 and p=0.250, respectively).Conclusion: Although statistically insignificant, metabolic prevalence increases in patients with fibromyalgia,while some MetS parameters, including waist circumference, and systolic and diastolic blood pressures, weresignificantly higher in fibromyalgia. Therefore, fibromyalgia patients may be under greater risk of MetS thanthe general population. For a definitive conclusion on the MetS and fibromyalgia, further large-scale studiesare needed.

🔖

Bu Makaleye Atıf Yap

DARÇIN, T., KÖSEOĞLU, H. K. (2020). Evaluation of Metabolic Syndrome Prevalence and Parameters in Patients with Fibromyalgia. The anatolian journal of family medicine (Online), Cilt: 3 - Sayı: 2, 167–172. https://ajindex.com/articles/365053

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res [Hoboken] 2010;62:600– 10
  2. Walitt B, Fitzcharles MA, Hassett AL, Katz RS, Häuser W, Wolfe F. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol2011;38:2238–46
  3. Busse JW, Ebrahim S, Connell G, Coomes EA, Bruno P, Malik K, et al. Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol. Syst Rev 2013;2:18
  4. Hawkins RA. Fibromyalgia: a clinical update. J Am Osteopath Assoc2013;113:680–9
  5. Ceko M, Bushnell MC, Gracely RH. Neurobiology underlying fibromyalgia symptoms. Pain Res Treat 2012;2012:585419
  6. Fitzcharles MA, Ste-Marie PA, Pereira JX; Canadian Fibromyalgia Guidelines Committee. Fibromyalgia: evolving concepts over the past 2 decades. CMAJ 2013;185(13):E645–E51
  7. Clauw DJ, Arnold LM, McCarberg BH; FibroCollaborative. The science of fibromyalgia. Mayo Clin Proc 2011;86:907–11
  8. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36(6):339–56
  9. Smith HS, Harris R, Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician 2011;14:E217–45
  10. Russell IJ, Larson AA. Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis. Rheum Dis Clin North Am 2009;35(2):421–35
  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486–97
  12. Sidiropoulos PI, Karvounaris SA, Boumpas DT. Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther2008;10:207
  13. Bergmann N, Gyntelberg F, Faber J. The appraisal of chronic stress and the development of the metabolic syndrome: a systematic review of prospective cohort studies. Endocr Connect 2014;3:R55–80
  14. Ferraz-Amaro I, González-Juanatey C, López-Mejias R, Riancho-Zarrabeitia L, González-Gay MA. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm2013;2013:710928
  15. Assumpção A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CA, et a